Wegovy 2.4 mg FlexTouch solution for injection Summary of Product Characteristics (SmPC)
The authors note that the decrease in leptin is less associated with satiety or subsequent energy intake, likely in part because leptin concentrations do not tend to change until several hours post food intake, with fluctuations more associated with longer-term regulation of energy balance. 4
Inhibition of RIP3 increased ADSC viability under OGD and modified the competency of adipogenesis, angiogenesis, and inflammation regulation
Weight Loss Goals or Athletic Performance If youre actively losing weight or engaging in intense physical training, your metabolic demands increase
While mild nausea, constipation, or loose stools are common when starting Wegovy, symptoms that interfere with daily activities or persist beyond a few days at each dose increase warrant medical attention